en · de · es · fr · pt
glossary-desk.peptides6823.com › Blog › Background And Development — Beginner to Advanced

Background And Development — Beginner to Advanced

By Editorial Desk · published 2026-01-28 · last reviewed 2026-03-15 · Blog

The short version of heptapeptide fits in a sentence. The long version — which is the one that helps — is below.

Reviewed 2026-03-15. Anything still debated is marked as such rather than presented as settled.

Background and Development

Semax is a synthetic heptapeptide developed in the Soviet Union during the 1980s by researchers at the Institute of Molecular Genetics in Moscow. It was designed as a truncated analog of adrenocorticotropic hormone, retaining only the fragment spanning residues four through ten. Investigators sought a peptide that would preserve the cognitive effects associated with ACTH while eliminating the hormonal stimulation of the adrenal cortex. The compound entered clinical use in Russia during the following decade.

Russian regulatory authorities approved the peptide for nasal administration, and it remains listed in the national pharmacopoeia under several trade names. Documented indications include acute ischemic stroke, transient ischemic attacks, traumatic brain injury, and certain ophthalmological and neurological conditions. Physicians also prescribe it for cognitive complaints in older patients, although the evidence base for that use is thinner. Outside Russia and a few neighboring states, the substance is not an approved medicine and is sold instead as a research chemical.

Semax Background and Chemistry

Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It corresponds to the ACTH(4-7) fragment extended at the C-terminus by a Pro-Gly-Pro tripeptide, an addition intended to slow enzymatic breakdown. The molecular formula is C37H51N9O10S and the molecular mass is approximately 814 daltons. In the literature it is often described as an ACTH(4-10) analog, although that label reflects a naming convention as much as a precise structural relationship. The compound was developed in Russia and remains most closely associated with that research tradition.

Laboratory descriptions of the material are consistent across suppliers. It appears as a white to off-white lyophilized powder that dissolves readily in water and in polar organic solvents such as dimethyl sulfoxide. Aqueous solutions are clear and colorless at low concentrations. Because the peptide contains methionine, oxidation at the sulfur atom is a recognized degradation pathway, and handling notes usually call for protected, desiccated storage. Reported purity for research-grade lots is generally above 95 percent as measured by reversed-phase high-performance liquid chromatography.

Semax at a glance

PropertyValueNotes
Molecular classSynthetic heptapeptideAnalog of an ACTH fragment
Amino acid lengthSeven residuesMet-Glu-His-Phe-Pro-Gly-Pro
OriginMoscow, 1980sInstitute of Molecular Genetics
Approved regionsRussia and some neighboring statesNot cleared in Western markets
Common trade namesMultiple national brandsSold as a nasal formulation

Background and Development History

Semax is a synthetic peptide created in the Soviet Union during the early 1980s by researchers working in Moscow. It was built from the short adrenocorticotropic hormone fragment known as ACTH(4-10), and the chain was then extended with three additional amino acids. The resulting molecule was named semax and entered clinical use in Russia in 1994. It is generally described as a nootropic and neuroprotective agent rather than as a hormone analogue.

The parent fragment ACTH(4-10) carries the sequence Met-Glu-His-Phe-Arg-Trp-Gly. Semax replaces the arginine and tryptophan positions with a proline-glycine-proline tail, giving Met-Glu-His-Phe-Pro-Gly-Pro. That change removes residues associated with adrenal stimulation, so the peptide does not drive cortisol release the way full ACTH does. This distinction shapes how the compound is grouped in the literature, where it sits with neuropeptides and peptide neuromodulators rather than with corticosteroids.

Related pages on this site

Notes from published material

For services to Life Saving. Geoffrey Francis Norris, General Medical Practitioner, London. For services to Medicine. Arthur Joseph Nutter. For services to the Lieutenancy in Lancashire. John O'Neil, lately Principal Lecturer and Course Leader of PGCE Art and Design, University of Wales Institute, Cardiff. For services to Art Education and Teacher Training. Martin Offiah. For services to Rugby Football. Enid Rosalind Oliver. For services to the community in Ashford, Kent. William James Orford. For services to Cricket in the West Midlands. Vera Overs. For services to the community in Martindale, Cumbria. Clifford Owen. For services to the Chorley and District Talking Newspaper, Lancashire. Pamela Mary Owen. For services to the community, particularly the NHS, in Welshpool, Powys. Anthony Gerald Palmer. For services to the War Pensions Committee in East Anglia. Sarah Faith, The Honourable Mrs. Palmer. For services to the community, particularly the British Red Cross Society, in Berkshire. Isobel Marilyn Park. For services to the Scout Association in Dumfries. Gordon Seymour Passmore, Member, London Borough of Wandsworth. For services to Local Government. Norman Henry Pattenden, Special Operations Manager, North & South Railways Ltd. For services to the Railways Industry. William Evans Pattison. For services to Mountain Rescue. Robert John Patton. For services to the Engineering Industry. Christine Anne Pendlebury, Personal Secretary, Home Office. Philippa Helen Perks. For services to the community in Wrington, Bristol.

=== Terrorism === On 18 February 2018, while addressing a function in Washington, Bilawal Zardari said that there is a growing increase in terrorism in Pakistan and that democracy can win over extremism, but the biggest battle is of ideologies. "The battle is between modernity and extremism." Bilawal Zardari has also repeatedly criticized the government's resistance to implementing the National Action Plan, which he deems resistance to democracy and peace in the nation. He has also demanded the removal of three federal ministers accusing them of having connections with banned militant outfits. On 7 March 2019, during a provincial council meeting, Bilawal Zardari said, "I demand a joint parliamentary committee for implementation of National Action Plan and removal of all three federal ministers for their connection with extremist organisations. If our demands are not met, we will not support the government anymore." In a 2025 interview with Al Jazeera, Bilawal Zardari stated that Pakistan had no objection to extraditing individuals such as Hafiz Saeed and Masood Azhar to India as a confidence-building measure, provided New Delhi showed willingness to cooperate. He claimed Pakistan was ready to extradite "individuals of concern" as part of a broader dialogue on terrorism, but simultaneously cited legal and procedural obstacles. Despite both Saeed and Azhar being proscribed under Pakistan’s National Counter Terrorism Authority (NACTA), Bilawal Zardari argued that prosecuting them for cross-border terrorism was difficult.

=== 21st century === The 21st century was marked by the expansion of birth control. On June 15, 2000, the residency requirement for foreign women seeking an abortion was abolished, and on December 13, a law was passed that allows emergency contraception ("morning-after pill") to be issued to minors without parental consent. On July 4, 2001, the legal period for abortion was extended from 10 to 12 weeks, and then from 12 to 14 weeks on February 23, 2022. On December 6th, 2006, a report from the High Council for Population and Family, recommended free and anonymous contraception for minors. On March 25, 2013, a law was passed which includes full reimbursement of abortion and free access to medical contraception for minors over 15. On August 25, 2020, free contraception was extended to girls under the age of 15. On December 6, 2013, a law was enacted authorizing the trial of birthing centers.

Sources: en.wikipedia.org

Further detail

On 16 February, the Syrian government forces intensified their drone attacks, which resulted in the death of one person and five injuries in the Mansoura-Walgha village area. A car exploded in Al-Qurayya, injuring two people, a Syrian source stated that the car was carrying weapons and ammunition. On 17 February, the emir of Dar Ara, Abu Yahya Hassan Al-Atrash, defected to the Syrian government forces, arriving at Daraa Governorate from Suwayda, sources stated that Hikmat al-Hijri does not want other leaders in Suwayda, except him. On 19 February, an unknown group kidnapped Yahya al-Hajjar, the former leader of Men of Dignity, on his farm in rural Suwayda, the Men of Dignity declared a state of maximum alert immediately after the kidnapping, when al-Hajjar was released, he was taken to the guesthouse of the Men of Dignity leader, Sheikh Mazid Khaddaj. On 22 February, the Syrian government forces launched attacks toward Al-Majdal, the National Guard responded to the attacks. On 24 February, an armed group from the village of Labin attacked the Internal Security Forces after an attempt to free one of its members who had been arrested for theft. At the Suwayda headquarters of the Criminal Security branch, the Rapid Intervention Battalion, led by Ruad Abdul Khaliq, clashed with a group from the Abu Sarhan family.

== History == Viracor-IBT was created through the merger of two specialty diagnostic testing labs, Viracor Laboratories and IBT Laboratories. Founded by Dr. Konstance Knox and Dr. Donald Carrigan in Milwaukee County in 2000, Viracor was among the first to commercially offer real-time quantitative PCR assays to diagnose patients with Adenovirus, BK virus and JC virus, among others. Founded in 1983, IBT was the first laboratory to offer a test to definitively diagnose autoimmune causes of chronic hives and developed the first commercially available test to measure pneumococcal antibodies. On 1 July 2014, Ampersand Capital Partners completed the sale of Viracor-IBT Laboratories to Eurofins Scientific for $255 million. The company continued to be known as Viracor-IBT.

=== No development reported === ADX-71149 (JNJ-1813; JNJ-40411813; JNJ-mGluR2-PAM) – metabotropic glutamate mGlu2 receptor positive allosteric modulator [5] Tebideutorexant (JNJ-61393215; JNJ-3215) – orexin OX1 receptor antagonist [6]

Sources: en.wikipedia.org

Background from the literature

Mercury is commonly used in small scale gold mining. To do this, large amounts of mercury are usually mixed with gold-containing materials to create a gold-mercury alloy called amalgam. To separate the gold, the amalgam is heated in a furnace causing the mercury to vaporize. During this process, miners are directly exposed to mercury vapors, and surrounding communities may be indirectly exposed through contaminated air, water, and soil. Continuous high levels of mercury vapor inhalation can cause a variety of health effects. Inhalation may result in tremors, mood swings, muscle weakness, memory loss, or headaches. Prolonged exposure can lead to kidney damage, respiratory failure, and even death. Ingestion of mercury through contaminated water, food, or soil pose great risk to pregnant women and their developing fetuses. When born, this can impair the infants' cognitive functions, memory, language development, and fine motor skills. Despite its widespread use across countries, mercury exposure in artisanal small-scale gold mining is preventable. Mercury-free techniques like direct smelting result in gold recovery without the need of mercury resulting in the elimination of mercury. In this method, borax is used to decrease the viscosity and melting temperature of non-gold minerals so they can be easily separated from the gold. This not only results in improved worker and community health but also lower in cost and eco-friendly.

==== Diagnostic Statistical Manual assertion ==== DSM-IV lists General diagnostic criteria for a personality disorder guideline that "The pattern must not be better accounted for as a manifestation of another mental disorder, or to the direct physiological effects of a substance (e.g. drug or medication) or a general medical condition (e.g. head trauma).". As a result, AAS users may get misdiagnosed by a psychiatrist not told about their habit.

== History == In 1986 a Research Resource Facility Satellite Meeting was held in conjunction with the Sixth International Conference on Methods in Protein Sequence Analysis. The next year protein sequencing and amino acid samples were sent to survey 103 core facilities. By 1989 the ABRF was formally organized and incorporated. Each year an annual meeting was held as a satellite meeting of the Protein Society until 1996 when separate meetings began.

=== Detection === Codeine and its major metabolites may be quantitated in blood, plasma, or urine to monitor therapy, confirm a diagnosis of poisoning, or assist in a medico-legal death investigation. Drug abuse screening programs generally test urine, hair, sweat or saliva. Many commercial opiate screening tests directed at morphine cross-react appreciably with codeine and its metabolites, but chromatographic techniques can easily distinguish codeine from other opiates and opioids. Codeine usage results in significant amounts of morphine as an excretion product. Furthermore, heroin contains codeine (or acetyl codeine) as an impurity and its use will result in the excretion of small amounts of codeine. Poppy seed foods represent yet another source of low levels of codeine in one's biofluids. Blood or plasma codeine concentrations are typically in the 50–300 μg/L range in persons taking the drug therapeutically, 700–7,000 μg/L in chronic users, and 1,000–10,000 μg/L in cases of acute fatal over dosage. Codeine is produced in the human body along the same biosynthetic pathway as morphine. Urinary concentrations of endogenous codeine and morphine have been found to significantly increase in individuals taking L-DOPA for the treatment of Parkinson's disease.

Sources: en.wikipedia.org

Frequently asked questions

Where was Semax developed?

It originated at the Institute of Molecular Genetics in Moscow during the 1980s. The work was carried out by a Russian research group that specialized in peptide neuropharmacology.

Is Semax an approved medication anywhere?

It is registered as a medicine in Russia and has been used clinically there for decades. No regulatory agency in Western Europe or North America has approved it for any indication.

What is the relationship to ACTH?

Semax corresponds to the four-to-ten fragment of adrenocorticotropic hormone. Because it omits the first three residues, it lacks the adrenal-stimulating action of the full hormone.

Is semax an approved medicine?

It is registered as a pharmaceutical product in Russia, where it is typically supplied as a nasal solution. In most other countries it is not an approved drug and is traded as a research chemical instead. Approval status depends entirely on the jurisdiction involved.

Network